Modification of the histone H3 marker near the promoter of the SMAD2 gene may be observed in patients with thoracic aortic aneurysm; this is considered to be an epigenetic mechanism linked to SMAD2 overexpression [65]. The gene discussed is SMAD2; the disease is thoracic aortic aneurysm.